CMEA CAPITAL
CMEA closed in April of 2015 and has unveiled its new corporate identity as [Presidio Partners](https://www.crunchbase.com/organization/presidio-partners). CMEA Capital is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments. We believe that the most successful venture backed companies are those that are science based, with experienced teams that have a vision. As a result, CMEA typically invests in companies that have cutting edge an... d highly differentiated technology at their core and founding teams of the highest caliber still in place. These are companies that have the potential to transform their industries. CMEA Capital was founded in 1989 and maintains offices in San Francisco and Menlo Park. We invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies. Our partners and associates have extensive science, engineering, and operational backgrounds, providing us the confidence to look beyond today's technology. We apply our focus on science and teams to our collaborations with entrepreneurs and venture investment partners who are changing the world, one great company at a time.
CMEA CAPITAL
Industry:
Banking Finance Venture Capital
Founded:
1989-01-01
Status:
Closed
Technology used in webpage:
Apple Whitelist
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2015-05-01 | VYNE Therapeutics | CMEA Capital investment in Series A - VYNE Therapeutics | 14.3 M USD |
2015-04-20 | Cnano Technology | CMEA Capital investment in Series B - Cnano Technology | 15 M USD |
2014-10-07 | Jobvite | CMEA Capital investment in Series D - Jobvite | 25 M USD |
2014-05-15 | Sorbent Therapeutics | CMEA Capital investment in Series D - Sorbent Therapeutics | 6.5 M USD |
2014-05-08 | Arcadia Biosciences | CMEA Capital investment in Series D - Arcadia Biosciences | 33 M USD |
2014-03-04 | Neos Therapeutics | CMEA Capital investment in Series C - Neos Therapeutics | 15.5 M USD |
2014-01-08 | Auspex Pharmaceuticals | CMEA Capital investment in Series E - Auspex Pharmaceuticals | 20 M USD |
2013-11-04 | MediaSpike | CMEA Capital investment in Series A - MediaSpike | 5.2 M USD |
2013-07-15 | Mojo Networks | CMEA Capital investment in Series D - Mojo Networks | 10 M USD |
2013-04-01 | Spitfire Pharma | CMEA Capital investment in Venture Round - Spitfire Pharma | 500 K USD |